We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Neurology

Neurology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

High Basal Ganglia Perivascular Space Burden Predicts Both Ischemic Stroke and Major Bleeding in Antithrombotic Users
Neurologycerebral small vessel diseaseLiệu pháp chống huyết khối

High Basal Ganglia Perivascular Space Burden Predicts Both Ischemic Stroke and Major Bleeding in Antithrombotic Users

By MedXY|Mar 22, 2026

A large prospective study reveals that a high burden of basal ganglia enlarged perivascular spaces (BGPVSs) significantly increases the risk of both ischemic stroke and major bleeding in patients on antithrombotic therapy, positioning BGPVS

Selective D1/D5 Agonism: TEMPO-3 Trial Positions Tavapadon as a Significant Advancement for Parkinson’s Motor Fluctuations
NeurologyDopamine AgonistMotor Fluctuations

Selective D1/D5 Agonism: TEMPO-3 Trial Positions Tavapadon as a Significant Advancement for Parkinson’s Motor Fluctuations

By MedXY|Mar 22, 2026

The Phase 3 TEMPO-3 trial demonstrates that tavapadon, a selective D1/D5 agonist, significantly increases ‘good-on-time’ and reduces ‘off-time’ in Parkinson’s patients with motor fluctuations, offering a favorable sa

Beyond the Motor Cortex: Functional Network Mapping Redefines Cerebral Palsy Prediction After Neonatal Stroke
Neurologycerebral palsyConnectomics

Beyond the Motor Cortex: Functional Network Mapping Redefines Cerebral Palsy Prediction After Neonatal Stroke

By MedXY|Mar 20, 2026

A landmark study using lesion network mapping reveals that cerebral palsy after neonatal stroke is driven by disruptions in extensive functional networks, including the thalamus and cerebellum, rather than just localized motor cortex damage

Rethinking the Amygdala’s Role in Social Cognition: Preserved Empathy Motivation Despite Focal Lesions
Clinical UpdatesamygdalaEmpathy

Rethinking the Amygdala’s Role in Social Cognition: Preserved Empathy Motivation Despite Focal Lesions

By MedXY|Mar 20, 2026

This review analyzes evidence that amygdala damage, while impairing emotional recognition accuracy, does not diminish the intrinsic motivation to engage empathically, challenging traditional neurological models of psychopathy.

Beyond the Target: Why SBP Trajectories Predict Functional Recovery in Acute Intracerebral Hemorrhage
NeurologyBlood Pressure Managementclinical trials

Beyond the Target: Why SBP Trajectories Predict Functional Recovery in Acute Intracerebral Hemorrhage

By MedXY|Mar 20, 2026

A pooled analysis of 11,269 patients from the INTERACT and ATACH-II trials reveals that 24-hour systolic blood pressure trajectories, rather than just single targets, significantly influence functional outcomes after intracerebral hemorrhag

Recent Infections Act as a Transient Trigger for Cryptogenic Stroke in Young Adults via Thromboinflammatory Pathways
Infectious Diseasesinfectious diseasesThromboinflammation

Recent Infections Act as a Transient Trigger for Cryptogenic Stroke in Young Adults via Thromboinflammatory Pathways

By MedXY|Mar 18, 2026

The SECRETO study demonstrates that infections within the preceding week increase the odds of cryptogenic ischemic stroke by 2.6-fold in young adults, primarily driven by transient increases in von Willebrand Factor and Factor VIII levels.

Navigating the Diagnostic Overlap: Why 24 Percent of Patients Meeting Minimal MS Criteria for Optic Neuritis Require Antibody Testing
NeurologyMOGADmultiple sclerosis

Navigating the Diagnostic Overlap: Why 24 Percent of Patients Meeting Minimal MS Criteria for Optic Neuritis Require Antibody Testing

By MedXY|Mar 18, 2026

A multicenter study reveals that nearly one-quarter of patients meeting the newest multiple sclerosis criteria for optic neuritis actually have MOGAD or NMOSD, emphasizing the critical role of antibody screening and detailed orbital MRI in

PrimeC Shows Significant Long-term Functional Benefit and Reduced Mortality in ALS: Insights from the PARADIGM Trial
NeurologyALSclinical trials

PrimeC Shows Significant Long-term Functional Benefit and Reduced Mortality in ALS: Insights from the PARADIGM Trial

By MedXY|Mar 18, 2026

The Phase 2b PARADIGM trial reveals that PrimeC, a novel oral combination therapy, is safe and significantly slows functional decline and reduces the risk of death or hospitalization in ALS patients over 18 months.

The NIHSS Bias: Why Right-Sided Middle Cerebral Artery Strokes Carry Higher Mortality and Complication Risks
Emergency Medicineacute ischemic strokehealth equity

The NIHSS Bias: Why Right-Sided Middle Cerebral Artery Strokes Carry Higher Mortality and Complication Risks

By MedXY|Mar 15, 2026

A retrospective study of 489,360 patients reveals that right-sided middle cerebral artery strokes are associated with significantly higher inpatient mortality and complications compared to left-sided strokes, likely due to inherent scoring

Disentangling Cognitive Decline: The Interplay of White Matter Hyperintensities and Cortical Metabolism in Amyloid-Negative Patients
Clinical Updatescognitive impairmentglucose metabolism

Disentangling Cognitive Decline: The Interplay of White Matter Hyperintensities and Cortical Metabolism in Amyloid-Negative Patients

By MedXY|Mar 15, 2026

This review synthesizes findings on how periventricular white matter hyperintensities (PWMHs) drive cognitive impairment in Aβ-negative individuals through distinct metabolic mediation and direct structural pathways, highlighting the clinic

High-Frequency TENS Shows Promise for Nociplastic Ocular Pain in Randomized Pilot Trial
NeurologyneuromodulationOcular Pain

High-Frequency TENS Shows Promise for Nociplastic Ocular Pain in Randomized Pilot Trial

By MedXY|Mar 13, 2026

This randomized pilot study demonstrates that high-frequency TENS significantly improves specific neuropathic ocular pain symptoms over three months, offering a non-invasive, non-pharmacological alternative for patients with refractory ocul

Exoskeleton-Assisted Therapy for Upper Limb Motor Recovery in Early Subacute Stroke: Evidence from a Multicenter Randomized Controlled Trial
Clinical UpdatesExoskeletonneuroplasticity

Exoskeleton-Assisted Therapy for Upper Limb Motor Recovery in Early Subacute Stroke: Evidence from a Multicenter Randomized Controlled Trial

By MedXY|Mar 13, 2026

A comprehensive review of a multicenter RCT (Morone et al., 2026) demonstrating that exoskeleton-based robot-assisted therapy significantly improves upper limb motor impairment and clinical outcomes in the early subacute phase of stroke rec

Somatic Mosaicism in the Motor Cortex: A New Frontier in Understanding Sporadic ALS Pathogenesis
NeurologyALSFUS Protein

Somatic Mosaicism in the Motor Cortex: A New Frontier in Understanding Sporadic ALS Pathogenesis

By MedXY|Mar 12, 2026

This study identifies somatic gene mutations in excitatory neurons of the motor cortex as a potential driver of sporadic ALS, challenging the traditional view of the disease’s genetic origins.

Beyond Aging: Traumatic Brain Injury and Depression Emerge as Leading Predictors of Dementia in US Veterans
NeurologyAlzheimer's diseaseMillion Veteran Program

Beyond Aging: Traumatic Brain Injury and Depression Emerge as Leading Predictors of Dementia in US Veterans

By MedXY|Mar 12, 2026

A large-scale analysis of the VA Million Veteran Program reveals that TBI, depression, and specific military environmental exposures significantly elevate the 10-year risk of Alzheimer’s and related dementias, highlighting critical targets

Optimizing Prehospital Pathways: Impact of the Iranian Comprehensive Code Stroke Management Program (ICSM Phase III) on Thrombolysis Rates
Clinical UpdatesalteplaseEmergency Medical Services

Optimizing Prehospital Pathways: Impact of the Iranian Comprehensive Code Stroke Management Program (ICSM Phase III) on Thrombolysis Rates

By MedXY|Mar 11, 2026

This review analyzes the ICSM Phase III study, highlighting how a structured empowerment program and standardized protocols in EMS significantly reduced prehospital delays and tripled alteplase administration rates for acute ischemic stroke

Sport-Related Head Exposure Characteristics and Health Outcomes in Former Collegiate Athletes: A CARE Consortium Study
NeurologyCollegiate Athleticsmental health

Sport-Related Head Exposure Characteristics and Health Outcomes in Former Collegiate Athletes: A CARE Consortium Study

By MedXY|Mar 11, 2026

A study of 3,910 former college athletes found that a history of multiple concussions is significantly linked to worse mental health and sleep quality within five years of retirement, though most remain within normal clinical ranges.

High-Level EBNA-1 Antibodies: A Precise Biomarker for Differentiating Multiple Sclerosis From MOGAD and NMOSD
NeurologybiomarkersEBNA-1

High-Level EBNA-1 Antibodies: A Precise Biomarker for Differentiating Multiple Sclerosis From MOGAD and NMOSD

By MedXY|Mar 11, 2026

A large-scale multicenter study reveals that persistent high-level Epstein-Barr nuclear antigen 1 (EBNA-1) peptide antibody titers serve as a highly specific biomarker, effectively distinguishing Multiple Sclerosis from other neuroinflammat

Distinctive Endocrine Profiles and Hyperphagia in Rare Genetic Neurodevelopmental Disorders: Beyond the Prader-Willi Paradigm
Clinical UpdatesGhrelinHội chứng Prader-Willi

Distinctive Endocrine Profiles and Hyperphagia in Rare Genetic Neurodevelopmental Disorders: Beyond the Prader-Willi Paradigm

By MedXY|Mar 11, 2026

This review synthesizes findings from a national multicenter study identifying that hyperghrelinemia is a specific biomarker for Prader-Willi Syndrome, whereas other rare neurodevelopmental disorders exhibit normal ghrelin levels despite se

Revascularization Strategies in Isolated Vertebral Artery Occlusion: Clinical Implications of the BRAVO Study
Clinical UpdatesĐộng mạch đốt sốngischemic stroke

Revascularization Strategies in Isolated Vertebral Artery Occlusion: Clinical Implications of the BRAVO Study

By MedXY|Mar 11, 2026

The BRAVO study provides critical evidence that while IV thrombolysis improves recovery in isolated vertebral artery occlusion, endovascular treatment may increase risks unless reserved for severe cases.

Purine Biosynthetic Enzyme PAICS as a Central Mediator of DNA Damage and Cerebellar Atrophy in C9orf72-ALS
Clinical UpdatesALSC9orf72

Purine Biosynthetic Enzyme PAICS as a Central Mediator of DNA Damage and Cerebellar Atrophy in C9orf72-ALS

By MedXY|Mar 11, 2026

This review synthesizes recent evidence identifying PAICS downregulation as a critical link between C9orf72 loss-of-function, DNA repair failure, and cerebellar neurodegeneration, highlighting its potential as a therapeutic target.

Prev
16 / 25
1…1415161718…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles